1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-analytic and analytic validation of automated PTEN immunohistochemistry to detect PTEN loss in prostate cancer
    Meeting Abstract

    Morals, C.; Gopalan, A.; Hicks, J.; Reuter, V.; Scher, H.; De Marzo, A.; Lotan, T.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Pre-analytic and analytic validation of automated PTEN immunohistochemistry to detect PTEN loss in prostate cancer
    Meeting Abstract

    Morais, C.; Gopalan, A.; Hicks, J.; Reuter, V.; Scher, H.; De Marzo, A.; Lotan, T.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Prognostic importance of functional capacity for pre-transplant risk assessment among patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Jones, L. W.; Devlin, S.; Maloy, M.; Espiritu, N.; Aquino, J.; Hall, C.; Wood, W. A.; Michalski, M.; Gyurkocza, B.; Giralt, S.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • PIGF/Nrp1/VEGFR1 axis is upregulated in gestational trophoblastic disease
    Meeting Abstract

    Hussein, Y.; Snuderl, M.; Aghajanian, C.; Chiang, S.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • PIGF/Nrp1/VEGFR1 axis is upregulated in gestational trophoblastic disease
    Meeting Abstract

    Hussein, Y.; Snuderl, M.; Aghajanian, C.; Chiang, S.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J. R.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • ERG and PTEN protein expression in high risk (high volume, high Gleason grade, high pT stage) primary prostate cancer and corresponding regional lymph node metastases
    Meeting Abstract

    Gopalan, A.; Bialik, A.; Sirintrapun, S.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Scher, H.; Tickoo, S.; Reuter, V.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save